Seeing Is Believing

Currently out of the existing stock ratings of Matthew Sheerin, 115 are a BUY (49.15%), 119 are a HOLD (50.85%).
Analyst Matthew Sheerin, currently employed at STIFEL, carries an average stock price target met ratio of 90.1% that have a potential upside of 22.65% achieved within 272 days.
Matthew Sheerin’s has documented 436 price targets and ratings displayed on 23 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on PRVA, Privia Health Group at 09-Apr-2025.
Analyst best performing recommendations are on SONO (SONOS).
The best stock recommendation documented was for SONO (SONOS) at 8/27/2018. The price target of $20 was fulfilled within 1 day with a profit of $1.08 (5.71%) receiving and performance score of 57.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$110
$-9.97 (-8.31%)
$99
4 months 21 days ago
(08-Jun-2025)
6/9 (66.67%)
$-13.28 (-10.77%)
56
Sell
$98
$-21.97 (-18.31%)
$100
8 months 23 days ago
(06-Feb-2025)
8/9 (88.89%)
$-8.98 (-8.39%)
312
Hold
$120
$0.03 (0.03%)
$141
11 months 29 days ago
(31-Oct-2024)
11/14 (78.57%)
$-1.03 (-0.85%)
100
Buy
$135
$15.03 (12.53%)
$140
11 months 29 days ago
(31-Oct-2024)
1/5 (20%)
$13.97 (11.54%)
90
Hold
$132
$12.03 (10.03%)
$132
1 years 5 months 2 days ago
(27-May-2024)
5/5 (100%)
$1.78 (1.37%)
11
What Year was the first public recommendation made by Matthew Sheerin?